Vikram Sinha - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Vikram Sinha

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Clinical Pharmacology and Therapeutics|September 24, 2019

Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsMalidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.

Clinical Pharmacology and Therapeutics|March 20, 2025

ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global ConvergenceKellie Reynolds, Xinning Yang, Sheila Annie Peters, et al.

Journal of Pharmacokinetics and Pharmacodynamics|October 8, 2014

Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshopKlaus Romero, Vikram Sinha, Sandra Allerheiligen, et al.

Arthritis & Rheumatology (Hoboken, N.J.)|April 17, 2023

Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial DesignLaura E Schanberg, Lily Yeruk Mulugeta, Bolanle Akinlade, et al.

Clinical Pharmacology and Therapeutics|April 24, 2021

A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 MutationMalidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.

Pageof 5

Search research articles

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Clinical Pharmacology and Therapeutics|September 24, 2019

Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsMalidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.

Clinical Pharmacology and Therapeutics|March 20, 2025

ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global ConvergenceKellie Reynolds, Xinning Yang, Sheila Annie Peters, et al.

Journal of Pharmacokinetics and Pharmacodynamics|October 8, 2014

Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshopKlaus Romero, Vikram Sinha, Sandra Allerheiligen, et al.

Arthritis & Rheumatology (Hoboken, N.J.)|April 17, 2023

Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial DesignLaura E Schanberg, Lily Yeruk Mulugeta, Bolanle Akinlade, et al.

Clinical Pharmacology and Therapeutics|April 24, 2021

A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 MutationMalidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.

Pageof 5